Literature DB >> 11854720

Surgical management of atherosclerotic renovascular disease.

Gregory S Cherr1, Kimberley J Hansen, Timothy E Craven, Matthew S Edwards, John Ligush, Pavel J Levy, Barry I Freedman, Richard H Dean.   

Abstract

OBJECTIVE: This review describes the clinical outcome of surgical intervention for atherosclerotic renovascular disease in 500 consecutive patients with hypertension.
METHODS: From January 1987 to December 1999, 626 patients underwent operative renal artery (RA) repair at our center. A subgroup of 500 patients (254 women and 246 men; mean age, 65 plus minus 9 years) with hypertension (mean blood pressure, 200 plus minus 35/104 plus minus 21 mm Hg) and atherosclerotic RA disease forms the basis of this report. Hypertension response was determined from preoperative and postoperative blood pressure measurements and medication requirements. Change in renal function was determined with estimated glomerular filtration rates (EGFRs) calculated from serum creatinine levels. Proportional hazards regression models were used for the examination of associations between selected preoperative parameters, blood pressure and renal function response, and eventual dialysis-dependence or death.
RESULTS: Two hundred three patients underwent unilateral RA procedures, 297 underwent bilateral RA procedures, and 205 patients underwent combined renal and aortic reconstruction. After surgery, there were 23 deaths (4.6%) in the hospital or within 30 days of surgery. Significant and independent predictors of perioperative death included advanced age (P <.0001; hazard ratio [HR], 3.23; 95% confidence interval [CI], 1.85 to 5.70) and clinical congestive heart failure (P =.013; HR, 3.05; 95% CI, 1.26 to 7.34). Among the patients who survived surgery, hypertension was considered cured in 12%, improved in 73%, and unchanged in 15%. For the entire group, renal function increased significantly after operation (preoperative versus postoperative mean EGFR, 41.1 plus minus 23.9 versus 48.2 plus minus 25.5 mL/min/m(2); P <.0001). For individual patients, with a 20% or more change in EGFR considered significant, 43% had improved renal function (including 28 patients who were removed from dialysis-dependence), 47% had unchanged function, and 10% had worsened function. Preoperative renal insufficiency (P <.001; HR, 2.35; 95% CI, 1.86 to 2.98), diabetes mellitus (P =.007; HR, 2.14; 95% CI, 1.15 to 3.97), prior stroke (P =.042; HR, 1.50; 95% CI, 1.02 to 2.22), and severe aortic occlusive disease (P =.003; HR, 1.69; 95% CI, 1.19 to 2.31) showed significant and independent associations with death or dialysis during the follow-up examination period. After operation, blood pressure cured (P =.014; HR, 0.52; 95% CI, 0.30 to 0.88) and improved renal function (P =.011; HR, 0.40; 95% CI, 0.19 to 0.81) showed significant and independent associations with improved dialysis-free survival rate. All categories of function response and time to death or dialysis showed significant interactions with preoperative EGFR.
CONCLUSION: The surgical correction of atherosclerotic renovascular disease resulted in blood pressure benefit and retrieval of renal function in selected patients with hypertension. The patients with cured hypertension or improved EGFR after operation showed increased dialysis-free survival as compared with other patients who underwent surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854720     DOI: 10.1067/mva.2002.120376

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

Review 1.  Renovascular hypertension: is there still a role for stent revascularization?

Authors:  Stephen C Textor
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-09       Impact factor: 2.894

Review 2.  Renal artery stenosis: medical versus interventional therapy.

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 3.  Renal artery stenosis: optimizing diagnosis and treatment.

Authors:  William R Colyer; Ehab Eltahawy; Christopher J Cooper
Journal:  Prog Cardiovasc Dis       Date:  2011 Jul-Aug       Impact factor: 8.194

4.  Surgical Treatment of Abdominal Aortic Aneurysm with Congenital Solitary Pelvic Kidney and Superior Mesenteric Artery Stenosis.

Authors:  Takaaki Saito; Hiroki Tanaka; Naoto Yamamoto; Kazunori Inuzuka; Masaki Sano; Naoki Unno
Journal:  Ann Vasc Dis       Date:  2016-06-07

Review 5.  Total Renal Artery Occlusion: Recovery of Function After Revascularization.

Authors:  Sandhya Manohar; Abdurrahman Hamadah; Sandra M Herrmann; Stephen C Textor
Journal:  Am J Kidney Dis       Date:  2018-02-09       Impact factor: 8.860

6.  Spleno-renal artery transposition in a solitary functioning kidney for treatment-resistant hypertension and acute kidney injury.

Authors:  Subash Somalanka; Fiona E Harris; Eric Chemla; Rebecca Jo Suckling; Pauline A Swift
Journal:  BMJ Case Rep       Date:  2017-08-16

7.  Diastolic function predicts survival after renal revascularization.

Authors:  Racheed J Ghanami; Hamza Rana; Timothy E Craven; John Hoyle; Matthew S Edwards; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2011-08-06       Impact factor: 4.268

8.  Atherosclerotic renovascular disease among hypertensive adults.

Authors:  Ross P Davis; Jeffrey D Pearce; Timothy E Craven; Phillip S Moore; Matthew S Edwards; Christopher J Godshall; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2009-09       Impact factor: 4.268

Review 9.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

10.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Authors:  Kirandeep K Khangura; Alfonso Eirin; Garvan C Kane; Sanjay Misra; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2013-10-25       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.